checkAd

     109  0 Kommentare Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results - Seite 3

    Lesen Sie auch


    The Apyx Medical Corporation Stock at the time of publication of the news with a fall of -0,83 % to 2,38USD on Tradegate stock exchange (05. Januar 2024, 22:26 Uhr).

    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results - Seite 3 Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today reported preliminary revenue results for the fourth quarter and full year …